BAY 2686013

BAY 2686013
Identifiers
  • 2-amino-N-[4-[[3,5-bis(trifluoromethyl)phenyl]methoxy]phenyl]acetamide
CAS Number
PubChem CID
Chemical and physical data
FormulaC17H14F6N2O2
Molar mass392.301 g·mol−1
3D model (JSmol)
  • C1=CC(=CC=C1NC(=O)CN)OCC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F
  • InChI=1S/C17H14F6N2O2/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)9-27-14-3-1-13(2-4-14)25-15(26)8-24/h1-7H,8-9,24H2,(H,25,26)
  • Key:YHGBLECINAKBKX-UHFFFAOYSA-N

BAY 2686013 is a drug used in scientific research which acts as a selective antagonist of the pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and is expected to be useful for characterizing the function of this receptor.[1]

See also

References

  1. ^ Langer G, Scott J, Lind C, Otto C, Bothe U, Laux-Biehlmann A, Müller J, le Roy B, Irlbacher H, Nowak-Reppel K, Schlüter A, Davenport AJ, Slack M, Bäurle S (September 2023). "Discovery and In Vitro Characterization of BAY 2686013, an Allosteric Small Molecule Antagonist of the Human Pituitary Adenylate Cyclase-Activating Polypeptide Receptor". Molecular Pharmacology. 104 (3): 105–114. doi:10.1124/molpharm.122.000662. PMID 37348913.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.